Related Experiment Video
Updated: Mar 19, 2026
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
The first cardioverter defibrillator implanted in Central Africa
Tantchou Tchoumi Jacques Cabral1, Appolonia Budzee1, Gianfranco Butera2
1St Elizabeth Catholic General Hospital, Cardiac Centre, Kumbo, Cameroon.
Insights
Sudden cardiac death remains a major health issue. Implantable cardioverter-defibrillators offer a promising management strategy, with the first documented cases now reported in Africa.
Area of Science:
- Cardiology
- Medical Devices
- Public Health
Background:
- Sudden cardiac death (SCD) causes 350,000 deaths annually, representing a significant healthcare challenge.
- Current antiarrhythmic drugs show limited efficacy in preventing SCD.
- While beta-blockers, ACE inhibitors, and revascularization aid in prevention, the implantable cardioverter-defibrillator (ICD) has emerged as a key management tool.
Purpose of the Study:
- To document the initial implantation of an implantable cardioverter-defibrillator (ICD) in Central, Eastern, and Western Africa.
- To highlight the expansion of advanced cardiac care to underserved regions.
Main Methods:
- Retrospective case report of the first ICD implantation in the specified African regions.
- Review of patient data and procedural outcomes.
Main Results:
- Successful implantation of an ICD was achieved.
- This marks a significant milestone in cardiac device therapy accessibility in Africa.
Conclusions:
- The implantable cardioverter-defibrillator (ICD) represents a critical advancement in managing sudden cardiac death.
- This report signifies the initiation of advanced arrhythmia management in previously underserved regions of Africa.
Abstract:
Sudden cardiac deaths, which account for approximately 350 000 deaths each year, is a major health care problem. Antiarrhythmic drugs have not been reliable in preventing sudden cardiac death. Although β-blockers, angiotensin-converting enzyme inhibitors, and revascularization play a role in prevention of sudden cardiac death, the development and subsequent refinement of the implantable cardioverter-defibrillator has made the most important contribution to its management. We report the first documented implantation of a cardioverter defibrillator in central, eastern and western Africa.
Related Concept Videos
01:23Cardiopulmonary Resuscitation III: AED Use
01:29Cardiomyopathy V: Interprofessional Care